1 min read
Add as a preferred source on GoogleAquestive Therapeutics Signs Exclusive Libervant License With Eton
Libervant is a diazepam buccal film used to treat seizures. Aquestive shares rose in premarket trading Wednesday.
Aquestive Therapeutics shares rose in premarket trading Oct. 14 after the company granted Eton Pharmaceuticals an exclusive license covering Libervant, its diazepam buccal film for treating seizures.
The agreement concerns an anti-seizure medication delivered as a film placed inside the cheek.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.